TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -2 | -10 | -15 | -13 | 26 | 0 | -3 |
| S | %wins | 67 | 100 | 100 | 100 | 0 | 73 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/17 11:53 | 3/15/17 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Glucksmann Alexandra | MA | O | COO | S.d | -26 | 26.41 | 28 | -1 | -1 | 118 | D | -20 | 66 | 57 | 39 | 6 | 17 | 0 | -11 | -23 | -17 | ||||
2/16/17 18:39 | 2/15/17 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Glucksmann Alexandra | MA | O | COO | S.d | -123 | 20.58 | 11 | -6 | -5 | 118 | D | 46 | 22 | 43 | 31 | 34 | 30 | 31 | 5 | -5 | -10 | ||||
8/24/16 16:13 | 8/23/16 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Glucksmann Alexandra | MA | O | COO | S.d | -20 | 20.00 | 6 | -1 | -1 | 118 | D | -13 | -44 | -21 | -20 | 0 | 13 | 0 | -3 | -18 | -13 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |